Abstract: A plant illumination optical device includes two LED lamp bodies. Each of the LED lamp bodies includes a reflector and an LED lamp located at an inner side of the reflector, and an angle between the central light rays of the two LED lamp bodies is adjustable. A plant cultivation device contains the plant illumination optical device. The plant illumination optical device and the plant cultivation device can reflect the light beyond the planting area to the planting area and can supplement the illumination on both sides of the illumination centerline, thereby avoiding light waste, improving energy efficiency, improving the illumination uniformity in the planting area, and improving planting quality of the planting area.

Abstract: A radiator and a plant illumination lamp containing the radiator. The radiator includes a heat-radiating baseplate configured for fixing a heat source, and heat-radiating side plates connected to the heat-radiating baseplate. The heat-radiating side plates each are provided with a plurality of heat-exchanging through grooves running through the heat-radiating side plates. The heat-exchanging through groove forms a heat potential difference, so that under the influence of the heat potential difference, the cold air outside the radiator passes through the heat-exchanging through groove on the heat-radiating side plates, and then flows out through a hot air chamber and an air outlet at an upper end of the hot air chamber after exchanging heat with the heat-exchanging through groove on the heat-radiating side plates, so as to form a strong natural air convection.

Abstract: A device and method controlling working state change of a small cell and a base station including the device. The device includes: an information acquiring unit that acquires interference between a small cell to be controlled and an adjacent small cell and/or load of the small cell to be controlled; and a state change determination unit that determines working state change to be performed by the small cell to be controlled according to the acquired interference and/or load. The working state includes multiple sleep levels from low to high. A sleep degree of the small cell to be controlled in a low sleep level is less than a sleep degree of the small cell to be controlled in a high sleep level, the working state change being performed among multiple sleep levels.

Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.

Abstract: A device and method controlling working state change of a small cell and a base station including the device. The device includes: an information acquiring unit that acquires interference between a small cell to be controlled and an adjacent small cell and/or load of the small cell to be controlled; and a state change determination unit that determines working state change to be performed by the small cell to be controlled according to the acquired interference and/or load. The working state includes multiple sleep levels from low to high. A sleep degree of the small cell to be controlled in a low sleep level is less than a sleep degree of the small cell to be controlled in a high sleep level, the working state change being performed among multiple sleep levels.

Abstract: The present invention provides a selective CXCR4 binding peptide conjugate (“PC”), and a method for using and producing the same. In particular, the selective CXCR4 binding peptide conjugate of the invention comprises a peptide portion that selectively binds to CXCR4 and a medically useful compound, such as an imaging agent, a diagnostic agent, or a therapeutically or pharmaceutically active compound. In one particular embodiment, the selective CXCR4 binding peptide conjugate (“PC”) is of the formula: or a pharmaceutically acceptable salt thereof, wherein a, b, AA1, AA2, Ar1, X1, and AA3 are those defined herein. The peptide conjugate of the invention can be used in a variety of medical applications including, but not limited to, a targeted drug delivery or imaging a patient or diagnosing a patient for a disease or a clinical condition associated with overexpression and/or upregulation of CXCR4, such as cancers, HIV infection, and immune disorders.

Abstract: The present invention relates to a method and an apparatus for recording a flight log of an unmanned aerial vehicle (UAV), a storage medium and a computer device. A log message is generated, the log message is stored in a message storage area, and a buffer area obtains the log message in the message storage area. The log message buffered in the buffer area is written into a memory card when the log message buffered in the buffer area meets any of the following conditions. The conditions include: the log message buffered in the buffer area occupies a storage capacity that reaches a capacity threshold or the log message is buffered in the buffer area for a number of times that reaches a threshold number of times. Each log message is generated independently and each generated log message is written into the buffer area. The event trigger mechanism has good real-time performance and can effectively reduce a probability of log message loss.

Abstract: The present invention provides a compound that can be used for targeted drug delivery, imaging a patient, or diagnosing a subject for a clinical condition which is believed to be associated with overexpression and/or upregulation of CXCR4. In particular, the present invention provides a high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the Formula: P-(L-A)n (I) or a pharmaceutically acceptable salt thereof, and a method for using and producing the same. The high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the invention is useful in diagnosing, treating or imaging a patient. In compound of Formula (I), n is an integer from 1 to the sum of (the total number of amino acid resides in P and the total number of side-chain functional group in the amino acid residue of P); each A is independently a diagnostic agent, a therapeutic agent, or an imaging agent; L is a linker or absent; and P is a high affinity CXCR4 selective binding peptidyl ligand.

Abstract: A supported core-shell bimetallic catalyst with high selectivity for propane dehydrogenation, containing platinum (Pt) as active species, 3d transition metals (Fe, Co and Ni) as promoters and SBA-15 as support. The addition of 3d metals and the formation of Pt3d alloys in subsurface result in a core-shell bimetallic catalyst which promotes the propene selectivity by decreasing the d-band center of surface Pt atoms and facilitating the desorption of propene on Pt. In another aspect, the reduced usage of Pt is achieved with the addition of 3d transition metals as well as the increased utilization of Pt atoms. The catalyst can be effectively used as a catalyst for the preparation of propene by propane dehydrogenation and 85% of propene selectivity can be achieved in propane dehydrogenation.

Abstract: A molybdenum-vanadium bimetallic oxide catalyst and its application in the chemical looping oxidative dehydrogenation of alkane. The molecular formula of molybdenum-vanadium bimetallic oxide catalyst is MoVy and y represents the atomic molar ratio of vanadium and molybdenum. The supported MoVy catalyst is prepared by impregnation method, following the drying, calcination and tablet pressing. The reaction temperature was 450-550° C., and propane could be oxidized and dehydrogenated to propylene with high activity and selectivity, with propane conversion rate remaining at 30-40% and propylene selectivity at 80-90%. The fresh catalysts were reduced to the lower valence states with the lattice oxygen diffusion to propane. After the dehydrogenation, the reduced samples were regenerated to recover to the initial state and regain the lattice oxygen. During the redox cycles, the reaction performance remains stable, which can be used in the fixed bed reactor, moving bed reactor or circulating fluidized bed.

Abstract: In one embodiment described herein, fuel may be converted into syngas by a method comprising feeding the fuel and composite metal oxides into a reduction reactor in a co-current flow pattern relative to one another, reducing the composite metal oxides with the fuel to form syngas and reduced composite metal oxides, transporting the reduced composite metal oxides to an oxidation reactor, regenerating the composite metal oxides by oxidizing the reduced composite metal oxides with an oxidizing reactant in the oxidation reactor, and recycling the regenerated composite metal oxides to the reduction reactor for subsequent reduction reactions to produce syngas. The composite metal oxides may be solid particles comprising a primary metal oxide and a secondary metal oxide.

Abstract: A sleeve interference fastener including a conformable sleeve, wherein the conformable sleeve is comprised of at least one first material having a hardness of X, and a pin member, wherein the pin member is comprised of at least one second material having a hardness of Y, wherein X is sufficiently less than Y so that, in an installed position of an interference fit, at least a portion of the at least one first material of the conformable sleeve conforms to a contour of an inner surface of a hole of a composite structure so as to create a continuous electrical contact at an interface between the inner surface of the hole of the composite structure and the conformable sleeve.

Abstract: A communication apparatus, communication system and communication method. The related communication apparatus is used for aggregating, at a base station side, communication resources at different frequencies and/or different transmission time, wherein a scheduling resource among the aggregated communication resources is used for transmitting control information about the scheduling resource and scheduled resources. The communication apparatus includes: a grouping unit configured to divide the communication resources into groups based on characteristics of the communication resources, wherein the same group of the communication resource is indicated by the same piece of control information; and a sending unit configured to send the control information to a corresponding communication terminal side by the scheduling resource. The communication apparatus, communication system and communication method improve communication performance.

Abstract: The present invention provides method treating a subject suffering from a clinical condition associated with CXCR4 activity, said method comprising administering to a subject in need of such a treatment a therapeutically effective amount of a compound of the formula: or a pharmaceutically acceptable salt thereof, wherein a is 0 or 1; AA1 along with the sulfur atom that is attached thereto is 3-mercaptopropionic acid, optionally substituted cysteine, or optionally substituted homocysteine; AA2 along with the sulfur atom that is attached thereto is cysteine or homocysteine; Ar1 is an optionally substituted aryl; X1 is Arg, Dap, Dab, Orn, Lys, Dap(iPr), Dab(iPr), Orn(iPr), or Lys(iPr); X2 is Arg, Dap, Dab, Orn, Lys, Dap(iPr), Dab(iPr), Orn(iPr), Lys(iPr), a D-isomer thereof, or absent; X3 is Gly or absent; X4 is Phe, 2Nal, 1Nal, or absent; X5 is Gly or absent; R2 is —OR4 or —NHR5; R4 is H or alkyl; and R5 is H, alkyl, optionally substituted aryl, optionally substituted aralkyl.

Abstract: A thermal interface material includes at least one polymer, at least one thermally conductive filler; and at least one ion scavenger. In some embodiments, the ion scavenger is a complexing agent selected from the group consisting of: nitrogen containing complexing agents, phosphorus containing complexing agents, and hydroxyl carboxylic acid based complexing agents.

Abstract: The present invention provides a compound that can be used for targeted drug delivery, imaging a patient, or diagnosing a subject for a clinical condition which is believed to be associated with overexpression and/or upregulation of CXCR4. In particular, the present invention provides a high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the Formula: P-(L-A)n (I) or a pharmaceutically acceptable salt thereof, and a method for using and producing the same. The high affinity CXCR4 selective binding ligand peptide conjugate (PC) of the invention is useful in diagnosing, treating or imaging a patient. In compound of Formula (I), n is an integer from 1 to the sum of (the total number of amino acid resides in P and the total number of side-chain functional group in the amino acid residue of P); each A is independently a diagnostic agent, a therapeutic agent, or an imaging agent; L is a linker or absent; and P is a high affinity CXCR4 selective binding peptidyl ligand.

Abstract: A data display method and apparatus, a storage medium, and a terminal are provided. The method includes obtaining a data display request; and obtaining an entry in response to the data display request. The entry includes first target data and second target data, and the first target data and the second target data have a predetermined association relationship. The method also includes: displaying the first target data in a display interface; designating a space on the display interface for the second target data; and generating a mask layer. The mask layer has a size matching the designated space and covers the second target data. The method also includes determining a target region based on a user operation performed on the designated space; and displaying the second target data in the target region.

Abstract: The present invention provides compounds that are antagonists of CXCR4 and methods for using the same for treatment of a clinical condition associated with CXCR4 activation. In particular, compounds of the invention include cyclic peptides. Compounds of the invention can be used to treat a variety of clinical conditions, including but not limited to, cancers, pulmonary fibrosis, HIV infection, rheumatoid arthritis, and other immune disorders. In addition, compounds of the invention can also be used in stem cell therapy.

Abstract: A device and method controlling working state change of a small cell and a base station including the device. The device includes: an information acquiring unit that acquires interference between a small cell to be controlled and an adjacent small cell and/or load of the small cell to be controlled; and a state change determination unit that determines working state change to be performed by the small cell to be controlled according to the acquired interference and/or load. The working state includes multiple sleep levels from low to high. A sleep degree of the small cell to be controlled in a low sleep level is less than a sleep degree of the small cell to be controlled in a high sleep level, the working state change being performed among multiple sleep levels.

Abstract: Novel redox based systems for fuel and chemical production with in-situ CO2 capture are provided. A redox system using one or more chemical intermediates is utilized in conjunction with liquid fuel generation via indirect Fischer-Tropsch synthesis, direct hydrogenation, or pyrolysis. The redox system is used to generate a hydrogen rich stream and/or CO2 and/or heat for liquid fuel and chemical production. A portion of the byproduct fuels and/or steam from liquid fuel and chemical synthesis is used as part of the feedstock for the redox system.